Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sana Biotechnology, Inc.

2.81
-0.0600-2.09%
Post-market: 2.820.0100+0.36%19:43 EDT
Volume:5.97M
Turnover:16.89M
Market Cap:633.81M
PE:-3.18
High:2.90
Open:2.90
Low:2.79
Close:2.87
Loading ...
Sep 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Feb 08, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Major Issues Report

Form 8-K - Current report